MCUJF Stock - Medicure Inc.
Unlock GoAI Insights for MCUJF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $21.91M | $21.69M | $23.07M | $21.74M | $11.61M |
| Gross Profit | $13.09M | $13.99M | $16.07M | $12.71M | $5.13M |
| Gross Margin | 59.7% | 64.5% | 69.7% | 58.5% | 44.2% |
| Operating Income | $-2,737,000 | $-854,000 | $1.31M | $-574,000 | $-7,287,000 |
| Net Income | $-1,039,000 | $-922,000 | $1.36M | $-727,000 | $-6,894,000 |
| Net Margin | -4.7% | -4.3% | 5.9% | -3.3% | -59.4% |
| EPS | $-0.10 | $-0.09 | $0.13 | $-0.07 | $-0.65 |
Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market in Canada and the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company offers ReDS, a non-invasive medical device that offers measurement of lung fluid for the management of congestive heart failure. Further, the company offers Sodium Nitroprusside injection for the reduction of blood pressure for adult and pediatric patients in hypertensive crisis, as well as for producing controlled hypotension to reduce bleeding during surgery, and for the treatment of acute congestive heart failure. It offers products through retail pharmacies, as well as online. The company was incorporated in 1997 and is headquartered in Winnipeg, Canada.
Visit WebsiteEarnings History & Surprises
MCUJFEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 19, 2026 | — | — | — | — |
Q4 2025 | Nov 19, 2025 | — | $-0.09 | — | — |
Q3 2025 | Aug 20, 2025 | — | $-0.06 | — | — |
Q2 2025 | Apr 25, 2025 | — | $-0.04 | — | — |
Q2 2025 | Apr 22, 2025 | — | $-0.04 | — | — |
Q4 2024 | Nov 25, 2024 | — | $0.05 | — | — |
Q3 2024 | Aug 14, 2024 | — | $-0.09 | — | — |
Q2 2024 | May 28, 2024 | — | $0.00 | — | — |
Q2 2024 | Apr 8, 2024 | — | $-0.10 | — | — |
Q4 2023 | Nov 21, 2023 | — | $0.01 | — | — |
Q3 2023 | Jul 28, 2023 | — | $0.01 | — | — |
Q2 2023 | Apr 10, 2023 | — | $0.03 | — | — |
Q2 2023 | Apr 6, 2023 | — | $0.03 | — | — |
Q4 2022 | Nov 23, 2022 | — | $0.08 | — | — |
Q3 2022 | Aug 24, 2022 | — | $-0.05 | — | — |
Q2 2022 | May 30, 2022 | — | $0.04 | — | — |
Q2 2022 | Apr 27, 2022 | — | $0.14 | — | — |
Q4 2021 | Nov 22, 2021 | — | $-0.07 | — | — |
Q3 2021 | Aug 27, 2021 | — | $-0.05 | — | — |
Q2 2021 | May 10, 2021 | — | $-0.08 | — | — |
Latest News
Frequently Asked Questions about MCUJF
What is MCUJF's current stock price?
What is the analyst price target for MCUJF?
What sector is Medicure Inc. in?
What is MCUJF's market cap?
Does MCUJF pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to MCUJF for comparison